MarketInOut Stock Screener Log In | Sign Up

Aarti Drugs Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 11:16
Aarti Drugs Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization34,135 mln
Float36.49 mln
Earnings Date11/10/2026

EPS

20.93
Exceptional

P / E

21.53
Premium valuation

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.26
Borderline

Relative Strength

96 / 100
Top performer

Debt / Equity

0.37
Low leverage

Business Description

Founded in 1984 and based in Mumbai, India, Aarti Drugs Limited produces and sells a wide range of medicines and chemical compounds both within India and across global markets. Through its subsidiaries, the company covers key treatment areas including diabetes, heart disease, fungal infections, and pain relief. It also manufactures specialty chemicals used in the production of pharmaceutical products by other companies.

Key Fundamentals

EPS20.93
P/E21.53
ROE13.08
RPS293
ROIC9.84
ROA7.17
Interest Cover7.64
EBITDA, mln3,341
EV / EBITDA13.48
EV / EBIT17.10
Revenue, mln26,776
EV / Revenue1.68

Quote Details

Last 450.95
Change 48.65 (12.09%)
Open 404.75
Volume 247,196
Turnover 111,473,040
Average Volume 20,119

Financial Ratios

Pre-Tax Profit Margin9
Leverage Ratio1.82
Current Ratio1.59
Price / Book2.54
Price / Tangible Book2.73
Price / Cash Flow22.46
Price / Free Cash Flow80.06
Debt / Equity0.37
Price / Sales1.47

Financial Strength

Altman Z-Score4.05
Piotroski F-Score 7 / 9
Beneish M-Score-2.26
Price to Intrinsic Value2.48
Price to Graham Number1.56
Shiller PE Ratio16.13

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 16.22% 99 / 100   
1 Month 5.51% 90 / 100   
2 Months 5.36% 77 / 100   
6 Months 17.83% 80 / 100   
1 Year -12.5% 56 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog